These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6314522)

  • 1. [In vitro comparison of the antibacterial activity of 1st, 2d, and 3d generation cephalosporins].
    Messmer JC; Lecaillon-Thibon E; Bon F; Soler H
    Sem Hop; 1983 Sep; 59(34):2389-92. PubMed ID: 6314522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
    Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multicenter study of the in vitro antibacterial activity of ceftazidime on gram-negative bacilli].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J; Thabaut A; Meyran M; Acar JF; Kitzis MD; Fleurette J; Coulet M
    Pathol Biol (Paris); 1983 May; 31(5):375-8. PubMed ID: 6353327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains.
    Dainelli B; Magni A; Maragoni F; Berlutti F; Thaller MC; Filadoro F
    G Batteriol Virol Immunol; 1981; 74(1-6):8-14. PubMed ID: 6458528
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria].
    Piccolomini R; Arpini A; Di Sipio L; Minelli G
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1450-6. PubMed ID: 7284112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro characterization of cefditoren, a new oral cephalosporin.
    Felmingham D; Robbins MJ; Ghosh G; Bhogal H; Mehta MD; Leakey A; Clark S; Dencer CA; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1994; 20(4):127-47. PubMed ID: 7813385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of antibacterial activities of cephalosporins].
    Kayser FH; Kohler ML
    Schweiz Med Wochenschr; 1984 Feb; 114(5):156-61. PubMed ID: 6701496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activity of 3d-generation cephalosporins and other antibiotics on recently isolated strains].
    Concia E; Perversi L; Monzillo V; Cruciani M
    G Ital Chemioter; 1986; 33(1):45-8. PubMed ID: 3817376
    [No Abstract]   [Full Text] [Related]  

  • 10. Compared sensitivities of 532 bacterial strains to six cephalosporins.
    Courtieu AL; Drugeon H
    Int J Clin Pharmacol Res; 1983; 3(3):195-201. PubMed ID: 6679522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the in-vitro activity of cefepime and other cephalosporins.
    Lim VK; Halijah MY
    Malays J Pathol; 1993 Jun; 15(1):65-8. PubMed ID: 8277793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the antibacterial activity of 3d generation cephalosporin antibiotics in vitro].
    Absolonová V; Wolfová J; Pribyslavská H; Bébrová E; Klazarová H; Klimesová M; Kawaciuková J; Nováková L; Lochmann O
    Cesk Epidemiol Mikrobiol Imunol; 1984 Sep; 33(5):282-90. PubMed ID: 6238680
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of cephalosporin antibiotics against Gram-positive bacteria.
    Kayser FH
    Postgrad Med J; 1971 Feb; 47():Suppl:14-20. PubMed ID: 5556186
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].
    de Vega JC; Pais JR; del Tánago AG
    Med Clin (Barc); 1980 May; 74(10):387-94. PubMed ID: 7412431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefdinir: in vitro activity study and effect of human serum.
    García-Rodríguez JA; Trujillano-Martín I; García-Sánchez JE
    Drugs Exp Clin Res; 1993; 19(2):51-8. PubMed ID: 8223142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.